# Mycoplasma Management in Commercial Poultry


## Key Takeaways

- *Mycoplasma gallisepticum* (MG) and *Mycoplasma synoviae* (MS) are significant economic pathogens in poultry, causing chronic respiratory disease and synovitis, respectively. Transmission occurs horizontally via aerosols, fomites, and direct contact, and vertically through the egg, making breeder flock health paramount.
- Effective management hinges on a structured framework of biosecurity, routine diagnostic surveillance (serology, PCR, culture), and veterinarian-led intervention decisions. Biosecurity measures include strict traffic control, all-in/all-out management, and thorough cleaning and disinfection to prevent pathogen introduction and spread.
- Diagnostic interpretation requires professional veterinary oversight, as serology indicates exposure but not necessarily active infection, and PCR can detect DNA from non-viable organisms. Confirmation of positive results with a second test and consideration of clinical history are crucial for accurate diagnosis.
- Intervention strategies include vaccination (live or killed), antibiotic treatment (e.g., tylosin, tilmicosin), and depopulation of infected breeder flocks. Antibiotics reduce clinical signs but do not eliminate infection, and concerns regarding antimicrobial resistance necessitate judicious use and adherence to withdrawal periods.
- Planning decisions, particularly for source flock management, are critical. Establishing mycoplasma-free breeding flocks and implementing rigorous biosecurity between age groups, especially in multi-age sites, are essential to prevent vertical and horizontal transmission.
- Emerging research explores genetic resistance factors (e.g., MMP7), plant-derived and subunit vaccines, and natural compounds like glycyrrhizic acid as potential adjunct therapies, aiming to reduce reliance on antibiotics and improve long-term sustainability of mycoplasma control programs.

---

Mycoplasma management in commercial poultry is a continuous biosecurity and monitoring effort that rests on understanding transmission pathways, implementing routine diagnostic surveillance, and making veterinarian-led decisions about source flock health and intervention timing. The pathogens *[Mycoplasma gallisepticum](/knowledge/bacteria/avian-bacteria/mycoplasma-gallisepticum-poultry-chronic-respiratory-disease-control)* (MG) and *[Mycoplasma synoviae](/knowledge/bacteria/avian-bacteria/mycoplasma-synoviae-infectious-synovitis-chickens-turkeys-eggshell-apex-abnormalities)* (MS) are among the most economically damaging agents in global poultry production, causing chronic respiratory disease, synovitis, and egg production losses. Control depends on a structured framework that addresses system context, planning decisions, and the core management cycle.

## At a Glance

| Key Point | Description | Decision Responsibility |
|-----------|-------------|------------------------|
| Pathogen transmission | Horizontal via aerosol, fomites, and direct contact, vertical through the egg | Flock manager and veterinarian |
| Monitoring methods | Serology, PCR, culture, sample type and frequency depend on flock age and production type | Veterinarian |
| Source flock context | Multi-age sites and replacement pullet origin determine risk | Production planner |
| Testing strategy | Baseline surveillance, pre-movement testing, and outbreak confirmation | Veterinarian and diagnostic lab |
| Control decisions | Vaccination, antibiotic use, depopulation, rely on diagnosis and risk assessment | Veterinarian |

## System Context and Transmission Dynamics

The epidemiology of mycoplasmosis differs between MG and MS, but both share essential transmission features. *[Mycoplasma gallisepticum](/knowledge/bacteria/avian-bacteria/mycoplasma-gallisepticum)* is the classic cause of chronic respiratory disease in chickens. It spreads horizontally through respiratory droplets, contaminated feed and water, and fomites such as footwear and equipment. Vertical transmission through the hatching egg also occurs, making breeder flock status a major determinant of progeny health. *Mycoplasma synoviae* causes synovitis and respiratory disease and exhibits similar transmission routes. The USDA National Animal Health Monitoring System and [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) both emphasize that eradication programs require eliminating infected breeder flocks and maintaining strict biosecurity between age groups.

Recent field work on Chinese indigenous chickens found that MS-positive rates increased significantly between 8 and 25 weeks of age, with no positive samples in chicks under 2 weeks, suggesting that horizontal transmission within flocks is the dominant driver after brooding. This age-dependent pattern highlights the need for surveillance timing tailored to production stage. The [Merck Veterinary Manual](https://www.merckvetmanual.com/) notes that concurrent infections with *Escherichia coli*, *[Ornithobacterium rhinotracheale](/knowledge/bacteria/avian-bacteria/ornithobacterium-rhinotracheale)*, or [infectious bronchitis virus](/knowledge/viruses/avian-viruses/infectious-bronchitis-virus) can exacerbate clinical signs, so diagnostic workup should rule out other respiratory pathogens.

## Planning Decisions for Source Flock Management

The single most effective control point is establishing mycoplasma-free breeding flocks. Planning begins at the pyramid top: hatchery source flocks must be tested and confirmed negative for both MG and MS before eggs are transferred to commercial multipliers. The [USDA APHIS Livestock and Poultry Disease](https://www.aphis.usda.gov/livestock-poultry-disease) resources describe the National Poultry Improvement Plan (NPIP) in the United States, which provides certification categories for mycoplasma-free status. For commercial production, the planning decision involves whether to source from NPIP-certified participants or to implement in-house monitoring and risk mitigation.

Multi-age production sites present the highest risk because older birds can shed mycoplasmas to younger cohorts. In such systems, planning decisions must include strict all-in-all-out flow between houses, dedicated equipment, and separate caretakers for each age group. The [FAO Animal Production and Health](https://www.fao.org/animal-production/en/) guidance stresses that planning should also account for cleanout periods between flocks, diagnostic sample size based on expected prevalence, and contingency budgets for depopulation if positive flocks are detected.

## Core Management Framework

The management framework comprises three interconnected phases: biosecurity, surveillance, and intervention. Biosecurity prevents introduction. Surveillance detects subclinical infection. Intervention reduces clinical impact and transmission. Each phase requires veterinarian oversight because diagnostic interpretation, vaccine selection, and withdrawal periods for antibiotics demand professional judgment. The framework must be documented and reviewed at least annually.

The first phase, biosecurity, includes physical barriers (rodent control, netted openings, footwear disinfection), traffic control, and water sanitation. Mycoplasmas are sensitive to drying and common disinfectants, but organic matter protects them, so cleaning surfaces before disinfection is mandatory.

Surveillance begins with a baseline assessment of the flock. A typical approach uses serology (ELISA or hemagglutination inhibition) combined with PCR on choanal cleft or tracheal swabs. The [USDA National Animal Health Monitoring System](https://www.aphis.usda.gov/livestock-poultry-disease/nahms) provides prevalence benchmarks from commercial flocks. Uncertainty arises because serology cannot distinguish past exposure from active infection, and PCR detects DNA from both viable and nonviable organisms. Culture remains the gold standard but is slow and requires specialized media. These limitations mean that positive screening results should be confirmed with a second test, and the veterinarian decides on response based on clinical history, production phase, and risk of spread to other sites.

Intervention options include vaccination (live or killed), antibiotic treatment, and, in breeding stock, depopulation. Live MG vaccines (e.g., ts-11, 6/85, F-strain) are used in layers and breeders but must not be used in meat chickens because they can cause disease under stress. Antibiotics such as tylosin, tilmicosin, and enrofloxacin can reduce clinical signs but do not eliminate infection. Residue concerns and antimicrobial resistance, as noted in the literature on [Glycyrrhizic Acid against Mycoplasma gallisepticum-Induced Inflammation](https://www.semanticscholar.org/paper/2ba1e8529f31d860ba86d80ce8b701e236b70dd6) (2022), suggest that alternative compounds like glycyrrhizic acid may become future options, but currently no commercial substitute exists for antibiotics.

Veterinarian-led decisions must weigh the cost of outbreak versus the cost of control. For example, depopulating a positive breeder flock eliminates vertical transmission but interrupts supply. Monitoring and treatment can maintain production with reduced efficiency but risk spread to downstream sites. The [PubMed record 42440868](https://pubmed.ncbi.nlm.nih.gov/42440868/) discusses the historic persistence of *[Mycoplasma gallisepticum](/knowledge/bacteria/avian-bacteria/mycoplasma-gallisepticum)* in commercial poultry despite control programs, underscoring that eradication requires sustained commitment.

Further sections will elaborate on diagnostic testing methods, interpretation of positive results, and a detailed breakdown of veterinarian-led control strategies.

## Facilities and Environment

Mycoplasma transmission in commercial poultry is primarily horizontal through direct contact, aerosolized respiratory secretions, and contaminated fomites [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/). Facilities must be designed for all-in/all-out management to break the pathogen cycle. Cleanout between flocks requires removal of litter, washing with detergent, disinfection, and adequate downtime. Field studies confirm that inadequate cleaning leads to carryover infection, especially in multi-age operations [FAO Animal Production and Health](https://www.fao.org/animal-production/en/).

The environment within houses influences both transmission and disease expression. Poor ventilation elevates ammonia and dust levels, which irritate respiratory epithelium and increase susceptibility to Mycoplasma gallisepticum (MG) colonization [Merck Veterinary Manual](https://www.merckvetmanual.com/). Litter moisture and pH management are similarly relevant: wet litter fosters ammonia release and may promote survival of mycoplasmas outside the host. Stocking density should be kept within guidelines to reduce aerosol transmission and stress-mediated shedding. Temperature fluctuations cause additional stress, triggering recrudescence in latently infected flocks.

## Nutrition and Water

Nutrition affects immune competence and the ability to suppress mycoplasma infection. Balanced rations with adequate vitamins A, E, and selenium support mucosal barrier integrity, though specific nutrient thresholds are not established for mycoplasma control [FAO Animal Production and Health](https://www.fao.org/animal-production/en/). Water quality is often overlooked but critical: high bacterial loads or chemical contaminants can cause gastrointestinal upset, inducing systemic stress that exacerbates mycoplasma signs. Providers should routinely test water sources and clean drinker lines. While antibiotic use is limited by regulations, phytogenic compounds such as glycyrrhizic acid have shown in vitro and in vivo inhibition of MG adhesion and inflammation through suppression of the MAPK pathway, offering a potential supportive strategy [Glycyrrhizic Acid against Mycoplasma gallisepticum-Induced Inflammation and Apoptosis Through Suppressing the MAPK Pathway in Chickens](https://www.semanticscholar.org/paper/2ba1e8529f31d860ba86d80ce8b701e236b70dd6). However, clinical application remains investigational.

## Production-Stage Decisions

Risk profiles differ across production stages and bird types. In broilers, Mycoplasma synoviae (MS) often presents as subclinical respiratory disease or synovitis, leading to lameness, reduced weight gain, and increased condemnations. Serological surveys from the [USDA National Animal Health Monitoring System](https://www.aphis.usda.gov/livestock-poultry-disease/nahms) indicate that MG and MS are prevalent in meat-type flocks, though many are asymptomatic under good management. In layers and breeders, both MG and MS cause drops in egg production, increased mortality, and vertical transmission. Breeder flocks require the highest level of control because infection spreads through the egg to progeny, perpetuating the cycle.

Age is a strong determinant: in Chinese indigenous chicken flocks, MS positivity by qPCR increased significantly from 8 to 25 weeks of age, while chicks younger than 2 weeks rarely tested positive [Transmission investigation of Mycoplasma synoviae in Chinese indigenous chickens](https://www.semanticscholar.org/paper/7520f39283799072ceff3b041819c7b79b04a72b). This suggests that younger birds may possess innate resistance or that exposure accumulates gradually. Management decisions should therefore include biosecurity measures that intensify as the flock ages. For breeders, serological monitoring and eradication programs are cost-effective in the long term compared with treating recurring outbreaks.

Vaccination decisions are veterinarian-led and depend on local disease pressure, production type, and regulatory constraints. Existing vaccines have limited efficacy, often requiring multiple doses and providing incomplete protection [A preliminary study of the immunogenic response of plant-derived multi-epitopic peptide vaccine candidate of Mycoplasma gallisepticum in chickens](https://www.semanticscholar.org/paper/2e0583937761336136fcce70ba509bdefd8d03c9). Novel multi-epitope peptide vaccines targeting cytoadherence proteins are in development but not yet commercially available. Similarly, multi-component subunit vaccines against MS have shown promise in preclinical studies but are not licensed [Target antigen screening and development of a multi-component subunit vaccine against Mycoplasma synoviae in chickens](https://www.semanticscholar.org/paper/a9932745c3893069f2023189cb143e493ee36fc2). Antibiotic therapy may reduce clinical signs but does not eliminate infection and carries risk of resistance, use should follow veterinary prescription and withdrawal periods.

## Records

Accurate record-keeping supports retrospective analysis and early detection of mycoplasma problems. Essential records include daily mortality, clinical signs graded by severity, and results of laboratory tests (serology, PCR, culture). Dates of introduction of new stock, vaccination, and treatments should be logged. The [USDA APHIS Livestock and Poultry Disease](https://www.aphis.usda.gov/livestock-poultry-disease) guidelines emphasize that records help identify patterns such as age at first seroconversion or seasonality of outbreaks. Production data (egg production curves, feed conversion, growth rates) provide indirect indicators: an unexplained drop often correlates with respiratory disease. Veterinarians evaluating flocks should have access to at least six months of records to detect trends.

## Welfare

Clinical mycoplasmosis directly compromises bird welfare. Respiratory rales, coughing, and nasal discharge indicate discomfort, lameness from MS synovitis impairs mobility and access to feed and water. In severe cases, mortality increases, but chronic morbidity is more common and harder to quantify. The [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) contains animal welfare standards that address disease prevention and humane handling. Flocks with confirmed mycoplasma infection should be monitored daily for progression, and culling of severely affected birds is sometimes warranted. Stress from handling, transport, or environmental extremes worsens clinical signs, so measures to reduce stress are part of welfare management.

## Worker and Food Safety

Mycoplasma gallisepticum and M. synoviae are not zoonotic and pose no direct food safety risk, but their management has indirect implications. Antibiotic treatments used to control signs can result in residues in meat and eggs if withdrawal times are not observed. Rigorous adherence to labeled withdrawal periods is legally required and protects consumer safety [FAO Animal Production and Health](https://www.fao.org/animal-production/en/). Workers in poultry houses may be exposed to high ammonia, dust, and endotoxin levels, especially when birds show respiratory signs. Personal protective equipment such as masks and goggles reduces occupational health risks. Biosecurity protocols should include hand washing and boot changes before and after handling infected flocks.

## Failure Patterns

Control programs can fail for several reasons. Incomplete biosecurity allows introduction from infected replacement stock, contaminated equipment, or personnel. Vaccination may fail due to maternal antibody interference, improper storage, or mismatch between vaccine strain and field strain. Antibiotic resistance has been documented in MG and MS, and treatment may suppress but not eradicate infection, leaving carrier birds that shed intermittently. The recent identification of matrix metalloproteinase 7 (MMP7) as a host resistance factor highlights genetic variability among birds: flocks with low MMP7 expression may be more susceptible [Matrix metalloproteinase 7 (MMP7) as a molecular target for Mycoplasma gallisepticum (MG) resistance in chickens](https://www.semanticscholar.org/paper/9091e7118224fd25d34ccc1dc04b708d4ebd25d2). Environmental stress events,such as heat waves or feed outages,can trigger outbreaks in previously subclinical flocks. Breeder flocks that become infected will persistently shed progeny, undermining on-farm eradication.

## Practical Monitoring

Effective monitoring combines clinical surveillance with laboratory testing. Serology using ELISA or rapid agglutination tests identifies exposure but cannot distinguish active infection from past exposure or vaccine response. PCR (especially qPCR) from choanal cleft or tracheal swabs is sensitive and specific for detecting current infection [Transmission investigation of Mycoplasma synoviae in Chinese indigenous chickens](https://www.semanticscholar.org/paper/7520f39283799072ceff3b041819c7b79b04a72b). Culture remains the gold standard but is slow and requires specialized media, it is used mainly when antimicrobial sensitivity is needed. Testing should target all production stages, with higher frequency in breeders and during high-risk periods such as placement of new flocks or after clinical signs. Sentinel birds (seronegative birds placed in the flock and tested later) can reveal cryptic transmission.

Most testing protocols involve periodic sampling of a statistical subset (e.g., 30 birds per house). Results should be interpreted by a veterinarian with knowledge of the farm history, because false positives and negatives occur. For instance, PCR can detect non-viable DNA from killed organisms. Professional escalation occurs when a flock shows rising titers, multiple positive PCR results, or clinical signs despite negative tests. Confirmatory testing at an accredited diagnostic laboratory is warranted [USDA APHIS Livestock and Poultry Disease](https://www.aphis.usda.gov/livestock-poultry-disease). Control decisions,whether to treat, depopulate, or alter management,are made by the veterinarian in consultation with the producer, referencing [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) and national regulations. Uncertainty remains common due to variable test performance, latent infections, and incomplete knowledge of local strain diversity, thus, monitoring should be continuous and adaptive.

### Health Observation and Biosecurity

Daily health observation of commercial poultry flocks is a primary tool for early detection of mycoplasma infection. Flock managers should assess feed and water consumption, respiratory sounds, egg production trends, and the presence of ocular or nasal discharge. In Mycoplasma gallisepticum (MG) infections, clinical signs may include rales, sneezing, coughing, and sinusitis. Mycoplasma synoviae (MS) often produces lameness, joint swelling, and breast blisters secondary to synovitis. However, subclinical infections are common, and signs become apparent only under environmental stress or concurrent viral infection. The [Merck Veterinary Manual](https://www.merckvetmanual.com/) notes that stress factors such as high stocking density, poor ventilation, and concurrent Newcastle disease or infectious bronchitis can exacerbate clinical disease.

Biosecurity remains the cornerstone of mycoplasma control. Standard protocols include:

- **Traffic control:** Restrict entry of personnel, equipment, and vehicles. Dedicated farm footwear and clothing reduce mechanical transfer.
- **All-in/all-out management:** Depopulation and thorough cleaning between flocks disrupt pathogen cycles.
- **Cleaning and disinfection:** Mycoplasmas are inactivated by heat (above 60°C) and common disinfectants such as quaternary ammonium compounds and bleach. However, organic material must be removed first.
- **Rodent and insect control:** These pests can carry mycoplasmas between houses.
- **Source flock isolation:** Ideally, all replacement stock should originate from flocks certified free of MG and MS by a recognized monitoring program. The [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) provides guidelines for establishing and maintaining mycoplasma-free compartments.

### Diagnostic Methods and Veterinary Escalation

Confirming mycoplasma infection requires laboratory testing. Commonly used methods include:

- **Serology:** Enzyme-linked immunosorbent assay (ELISA) and serum plate agglutination tests screen for antibodies. Seroconversion typically occurs one to three weeks post-infection. [USDA APHIS](https://www.aphis.usda.gov/livestock-poultry-disease) data from the National Animal Health Monitoring System describe serological prevalence patterns in U.S. flocks.
- **[Polymerase chain reaction](/knowledge/molecular-biology/polymerase-chain-reaction) (PCR):** Direct detection of MG or MS DNA from choanal cleft swabs or tracheal samples is more sensitive than culture. Real-time PCR (qPCR) is both rapid and species-specific. A recent investigation of MS transmission in Chinese indigenous chickens used qPCR and demonstrated that positivity rose sharply in birds aged 8 to 25 weeks (see [Transmission investigation of Mycoplasma synoviae in Chinese indigenous chickens](https://www.semanticscholar.org/paper/7520f39283799072ceff3b041819c7b79b04a72b)).
- **Culture:** Isolation is definitive but requires specialized media and several weeks. Mycoplasmas are fastidious and often overgrown by other bacteria.

Veterinary escalation is indicated when:

- Clinical signs appear in a previously negative flock.
- Surveillance testing detects positive results in a serologically negative group.
- Mortality or egg production losses exceed baseline.

The veterinarian interprets test results in context. False positives can occur with cross,reacting antibodies (e.g., between MG and MS). False negatives may result from early infection before seroconversion or from sampling error. Therefore, repeat testing or use of multiple methods is often recommended. The veterinarian also designs a control strategy, which may include:

- **Eradication:** Depopulation followed by thorough cleaning and repopulation with mycoplasma-free stock is the only guaranteed method for elimination. This is most feasible in single-age broiler or layer complexes.
- **Medication:** Antibiotics such as tylosin, tiamulin, or enrofloxacin reduce signs but do not eliminate infection. Resistance is a growing concern.
- **Vaccination:** Live vaccines (e.g., MG ts-11 or 6/85) are used in some layer and breeder programs. Efficacy varies, and vaccination can complicate serological monitoring.

### Uncertainty and Sustainability

Several factors introduce uncertainty in mycoplasma management. Strain variation can alter virulence, transmissibility, and antimicrobial susceptibility. The [PubMed record 42406229](https://pubmed.ncbi.nlm.nih.gov/42406229/) highlighted early work on pathogenicity differences among mycoplasma isolates. Vaccine efficacy is not absolute, and breakthrough infections occur. Testing limitations mean that low-level infections may evade detection, particularly in carrier birds.

Long-term sustainability requires reducing reliance on antibiotics and culling. Emerging research offers alternative approaches:

- **Genetic resistance:** A 2025 study identified the matrix metalloproteinase 7 (MMP7) gene as a factor in MG resistance in chickens ([Matrix metalloproteinase 7 (MMP7) as a molecular target for Mycoplasma gallisepticum (MG) resistance in chickens](https://www.semanticscholar.org/paper/9091e7118224fd25d34ccc1dc04b708d4ebd25d2)). Overexpression of MMP7 inhibited MG adhesion and modulated immune responses. Breeding programs could incorporate such markers.
- **Plant-derived vaccines:** A multi-epitope peptide vaccine designed from MG cytoadherence proteins and expressed in plants showed preliminary immunogenicity in chickens ([A preliminary study of the immunogenic response of plant-derived multi-epitopic peptide vaccine candidate of Mycoplasma gallisepticum in chickens](https://www.semanticscholar.org/paper/2e0583937761336136fcce70ba509bdefd8d03c9)). Such approaches may offer safer, cost-effective vaccination.
- **Subunit vaccines:** For MS, whole-genome sequencing of clinical strains enabled identification of conserved antigens, leading to a multi-component subunit vaccine that provided protection in trials ([Target antigen screening and development of a multi-component subunit vaccine against Mycoplasma synoviae in chickens](https://www.semanticscholar.org/paper/a9932745c3893069f2023189cb143e493ee36fc2)).
- **Natural compounds:** Glycyrrhizic acid, a constituent of licorice, suppressed MG-induced inflammation and apoptosis through the MAPK pathway in chickens ([Glycyrrhizic Acid against Mycoplasma gallisepticum-Induced Inflammation and Apoptosis Through Suppressing the MAPK Pathway in Chickens](https://www.semanticscholar.org/paper/2ba1e8529f31d860ba86d80ce8b701c236b70dd6)). This suggests potential for adjunct therapy.

These innovations, however, remain experimental. Implementation at scale will require field validation, regulatory approval, and economic analysis. The [FAO Animal Production and Health](https://www.fao.org/animal-production/en/) division provides guidance on integrating such technologies into existing management systems.

## Frequently Asked Questions

**1. Can mycoplasmas survive in litter between flocks?**
Mycoplasmas are fragile outside the host. Drying, heat, and most disinfectants inactivate them. However, survival for a few days in moist organic material is possible. Thorough cleaning and disinfection, along with downtime of at least 7 to 14 days, are recommended.

**2. Is it possible to treat mycoplasma without eliminating the flock?**
Antibiotics can suppress clinical signs and reduce shedding but rarely eliminate infection. Treated birds remain carriers and can infect new additions. Eradication through depopulation is the only way to guarantee a clean flock.

**3. How often should I test my flock?**
Testing frequency depends on the flock’s risk status. Certified mycoplasma-free flocks require periodic testing (e.g., every 8 to 12 weeks). Commercial flocks with unknown status should be tested at least quarterly and before any introduction of new birds.

**4. Can chickens be infected with both MG and MS at the same time?**
Yes, concurrent infections occur. Mixed infections can complicate clinical signs and diagnosis. PCR testing that differentiates species is essential. The [PubMed record 42353502](https://pubmed.ncbi.nlm.nih.gov/42353502/) described mixed [mycoplasma infections in poultry](/knowledge/bacteria/avian-bacteria/mycoplasma-infections-in-poultry-vaccination-strategies-and-control-programs).

**5. Do vaccines guarantee 100% protection?**
No. Vaccines reduce clinical disease and egg production losses but do not prevent colonization or transmission. Vaccinated flocks may still shed field strains. Monitoring must continue, and vaccination status must be considered when interpreting serology.

**6. What is the role of vertical transmission?**
Both MG and MS can be transmitted through the egg from infected breeders to progeny. This is a major route for introducing infection into commercial flocks. Sourcing chicks from certified mycoplasma-free breeders is the primary control measure.

**7. Should I test for mycoplasmas in my broiler flock?**
Broilers typically have a shorter lifespan (5 to 8 weeks), so clinical disease is less common unless severe. However, testing at slaughter via tracheal swabs can inform the health status of the supply chain and help identify subclinical infections in parent flocks.

**8. What biosecurity improvements have the greatest impact?**
Preventing introduction of new stock from untested sources is most critical. Next, controlling personnel movement through shower-in/shower-out protocols and dedicated equipment per house reduces spread. Air filtration is not widely used but can be considered for high-value breeder facilities.

---

**Educational Veterinary Notice:** This information is intended for educational purposes and does not replace consultation with a licensed veterinarian. Management decisions regarding mycoplasma control should be based on flock-specific risk assessment, diagnostic results, and professional veterinary guidance.

## Related Farming Guides

- [Broiler Chicken Farming Flock Management From Placement To Processing](/knowledge/animal-farming/poultry/broiler-chicken-farming-flock-management-from-placement-to-processing)
- [Layer Chicken Farming Pullet Development Egg Production Nutrition And Flock Health](/knowledge/animal-farming/poultry/layer-chicken-farming-pullet-development-egg-production-nutrition-and-flock-health)
- [Broiler House Ventilation Fundamentals](/knowledge/animal-farming/poultry/broiler-house-ventilation-fundamentals)
- [Poultry Farm Biosecurity Checklist](/knowledge/animal-farming/poultry/poultry-farm-biosecurity-checklist)
- [Poultry Mortality Investigation And Flock Records](/knowledge/animal-farming/poultry/poultry-mortality-investigation-and-flock-records)

## Related Clinical & Scientific Guides

* [Poultry Farm Fencing: Materials, Design, and Predator Exclusion](/knowledge/animal-farming/poultry/poultry-farm-fencing-materials-design-predator-exclusion)
* [Broiler House Wind Speed and Airflow Measurement](/knowledge/animal-farming/poultry/broiler-house-wind-speed-airflow-measurement)
* [Broiler House Heating Systems: Types and Efficiency](/knowledge/animal-farming/poultry/broiler-house-heating-systems-types-efficiency)


## References and Further Reading

- [FAO Animal Production and Health](https://www.fao.org/animal-production/en/)
- [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/)
- [USDA APHIS Livestock and Poultry Disease](https://www.aphis.usda.gov/livestock-poultry-disease)
- [Merck Veterinary Manual](https://www.merckvetmanual.com/)
- [USDA National Animal Health Monitoring System](https://www.aphis.usda.gov/livestock-poultry-disease/nahms)

> This article is educational and is not a substitute for veterinary diagnosis, treatment, public-health guidance, or regulatory reporting.